Table 3. Univariate analysis of hemorrhagic transformation(HT) or prognosis in patients with elevated or normal hs-cTnT levels.
| Variable | Elevated hs-cTnT(n = 49) | Normal hs-cTnT(n = 35) | P | OR (95%CI) |
|---|---|---|---|---|
| HT | 27/49(55.2) | 9/35(25.7) | 0.007* | 3.545(1.379–9.114) |
| Prognosis | ||||
| Death | ||||
| 3 mos. | 14/49(28.6) | 2/35(5.7) | 0.009* | 0.152(0.032–0.718) |
| 6 mos. | 15/49(30.6) | 5/33(15.2) | 0.110 | 0.405(0.131–1.252) |
| 12 mos. | 16/48 (33.3) | 6/32(18.8) | 0.152 | 0.462(0.158–1.348) |
| Disability | ||||
| 3 mos. | 16/35(45.7) | 11/33(33.3) | 0.297 | 1.684(0.630–4.501) |
| 6 mos. | 10/34(29.4) | 6/28(21.4) | 0.475 | 1.528(0.476–4.902) |
| 12 mos. | 7/32(21.9) | 4/26(15.4) | 0.531 | 1.540(0.397–5.973) |
| Death/disability | ||||
| 3 mos. | 30/49(61.2) | 13/35(37.1) | 0.029* | 2.672(1.092–6.537) |
| 6 mos. | 25/49(51.0) | 11/33(33.3) | 0.113 | 2.083(0.834–5.203) |
| 12 mos. | 23/48(47.9) | 10/32(31.3) | 0.138 | 2.024(0.792–5.170) |